E
CLDX icon

Ergoteles’s Celldex Therapeutics CLDX Stock Holding History

Ergoteles’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-35,629
Closed -$1.28M – 1106
2023
Q1 		$1.28M Sell
35,629
-391
-1% -$16.9K 0.05% 406
2022
Q4 		$1.61M Buy
+36,020
New +$1.29M 0.06% 328
2022
Q2 		– Sell
-11,702
Closed -$399K – 1681
2022
Q1 		$399K Sell
11,702
-4,459
-28% -$143K 0.02% 750
2021
Q4 		$624K Buy
+16,161
New +$704K 0.02% 561
2021
Q1 		– Sell
-31,500
Closed -$552K – 827
2020
Q4 		$552K Buy
+31,500
New +$567K 0.02% 432

Other funds holding CLDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return